Cancer News and Research

Latest Cancer News and Research

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

The National Heart, Lung and Blood Institute has awarded a total of $16.7 million to Irwin Bernstein, M.D., and Beverly Torok-Storb, Ph.D., both members of the Clinical Research Division at Fred Hutchinson Cancer Research Center. The Hutchinson Center grants represent part of a $170 million effort involving 18 teams of research scientists dedicated to developing stem- and progenitor-cell tools and therapies.

8 Oct 2009

Study suggest childhood cancer survivors are less likely to get married

Childhood cancer survivors typically suffer from the long-term effects of cancer treatment on physical health, and results of a new study suggest that social implications also exist, which may affect their chance of an "I do" at the altar.

8 Oct 2009

BC Cancer Agency scientists find major breakthrough in breast cancer

For the first time in history, BC Cancer Agency scientists in British Columbia, Canada have decoded all of the three billion letters in the DNA sequence of a metastatic lobular breast cancer tumour, a type of breast cancer which accounts for about 10 per cent of all breast cancers, and have found all of the mutations, or "spelling" mistakes that caused the cancer to spread.

8 Oct 2009

Global pharmaceutical market to grow by 4 - 6 percent: IMS Health

IMS Health reported today that the value of the global pharmaceutical market in 2010 is expected to grow 4 - 6 percent on a constant-dollar basis, exceeding $825 billion, driven by stronger near-term growth in the U.S. market.

8 Oct 2009

Sangamo declares pricing of common stock; grants option to purchase additional 450,000 shares

Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.

8 Oct 2009

Researchers identify tumor-suppressing genes to diagnose the phase of laryngeal cancer

Researchers at Henry Ford Hospital have identified tumor-suppressing genes that may provide a more accurate diagnosis of disease stage and survival for laryngeal cancer patients than current standards.

8 Oct 2009

CTRC-AACR San Antonio Breast Cancer Symposium to honor two leading breast cancer researchers

The CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers when it holds its 32nd annual meeting Dec. 9-13, in San Antonio.

8 Oct 2009

Pfizer-FRSQ Innovation Fund supports genetic study of inflammatory bowel disease and cancer

The first two research projects supported by the Pfizer-FRSQ Innovation Fund will investigate differences in the genetic code for inflammatory bowel disease and metastatic colorectal cancer. This research could lead to improved diagnosis and the development of individualized treatments for these diseases. These innovative projects are marshalling multidisciplinary teams of seasoned researchers from major Quebec research institutions.

8 Oct 2009

NHLBI awards $11 million to research on the biology of two fatal lung diseases

Researchers at National Jewish Health and four other research centers have been awarded an $11 million, two-year grant from the National Heart Lung and Blood Institute as part of the NIH Recovery Act that will allow a team of national scientists to delve deeply into the biology of two fatal lung diseases for which there are few therapeutic options.

8 Oct 2009

Hoana Medical to be showcased at the FiReGlobal : West Coast conference

FiReGlobal : West Coast is proud to announce that Hoana Medical, Inc. has been selected as a FiReStar company to be featured at the FiReGlobal : West Coast conference. FiReStar companies, both local and global, are pre-selected based on their potential to bring positive change to the world. These companies will be showcased throughout the conference, and at a FiReStar reception, during which local and global investors will be given the chance to meet company officers.

8 Oct 2009

Family and population based approaches sheds new light on the potential roles of common and rare forms of human genetic variation

In one of the first studies of its kind, an international team of researchers has uncovered a single-letter change in the genetic code that is associated with autism. The finding, published in the October 8 issue of the journal Nature, implicates a neuronal gene not previously tied to the disorder and more broadly, underscores a role for common DNA variation.

8 Oct 2009

Epizyme raises $32 million through its Series B financing

Epizyme, Inc., a biopharmaceutical company translating key discoveries in the field of epigenetics into novel pharmaceutical agents, announced today the closing of a $32 million Series B financing led by new investor Bay City Capital (BCC).

8 Oct 2009

Ethnicity plays a significant role in non-small cell lung cancer genetics: Study

Clinical research out of University Hospitals Case Medical Center has found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which may impact response to new cancer-fighting drugs.

8 Oct 2009

White House honors PET researcher with National Science Award

Joanna Fowler, Ph.D., a major contributor to brain research and a pioneer in molecular imaging, is being recognized by the White House with the National Medal of Science-the highest award for lifetime achievement in science. Eight other researchers will join Fowler to receive the award at a White House ceremony on October 7.

8 Oct 2009

Entest BioMedical applies for Phase II grant from National Cancer Institute

Entest BioMedical, Inc. a majority owned subsidiary of Bio-Matrix Scientific Group, Inc. announced today that it has applied for an Exploratory/Development Phase II grant from the National Cancer Institute (NCI).

8 Oct 2009

Aflac raises $1.16 million through a grant campaign for pediatric cancer treatment

Aflac announced that it has raised more than $1.16 million for the Aflac Cancer Center through a matching grant campaign with Causes on Facebook, making it the largest sponsored campaign in the history of Causes. The effort also resulted in 851,215 new members joining the Aflac Cancer Center Cause, helping to generate awareness and financial support during Childhood Cancer Awareness Month.

8 Oct 2009

NIH grants over $3.8 million to Asuragen

Asuragen, Inc. announced today that it has received over $3.8 million in new grant funding for 2009 from the Small Business Innovative Research (SBIR), Small Business Technology Transfer (STTR), and American Recovery and Reinvestment Act (ARRA) funded initiatives of the National Institutes of Health (NIH) to further its development of molecular diagnostics for oncology and genetic disease.

8 Oct 2009

NIH funds Triple Ring Technologies' X-ray imaging system development

Triple Ring Technologies, Inc., a leading provider of early-stage advanced research and development services, today announced that it has been awarded a Challenge Grant from the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), as part of the American Recovery and Reinvestment Act (ARRA).

8 Oct 2009

Genomic Health to present study results of Oncotype DX multi-gene expression test

Genomic Health, Inc. today announced that the company will present results from two studies at the American Society of Clinical Oncology (ASCO) 2009 Breast Cancer Symposium, taking place October 8 through October 10 at the San Francisco Marriott in San Francisco, California.

8 Oct 2009

NCI awards $11.5 million grant to UAB for cervical cancer research

The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center has won an $11.5 million grant from the National Cancer Institute (NCI) to explore groundbreaking cervical cancer research, prevention and treatment.

8 Oct 2009

Cancer News and Research

Latest Cancer News and Research

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

Study suggest childhood cancer survivors are less likely to get married

BC Cancer Agency scientists find major breakthrough in breast cancer

Global pharmaceutical market to grow by 4 - 6 percent: IMS Health

Sangamo declares pricing of common stock; grants option to purchase additional 450,000 shares

Researchers identify tumor-suppressing genes to diagnose the phase of laryngeal cancer

CTRC-AACR San Antonio Breast Cancer Symposium to honor two leading breast cancer researchers

Pfizer-FRSQ Innovation Fund supports genetic study of inflammatory bowel disease and cancer

NHLBI awards $11 million to research on the biology of two fatal lung diseases

Hoana Medical to be showcased at the FiReGlobal : West Coast conference

Family and population based approaches sheds new light on the potential roles of common and rare forms of human genetic variation

Epizyme raises $32 million through its Series B financing

Ethnicity plays a significant role in non-small cell lung cancer genetics: Study

White House honors PET researcher with National Science Award

Entest BioMedical applies for Phase II grant from National Cancer Institute

Aflac raises $1.16 million through a grant campaign for pediatric cancer treatment

NIH grants over $3.8 million to Asuragen

NIH funds Triple Ring Technologies' X-ray imaging system development

Genomic Health to present study results of Oncotype DX multi-gene expression test

NCI awards $11.5 million grant to UAB for cervical cancer research

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in